Ian D. Hay

2.2k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

Ian D. Hay is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Ian D. Hay has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 3 papers in Oncology. Recurrent topics in Ian D. Hay's work include Thyroid Cancer Diagnosis and Treatment (20 papers), Thyroid and Parathyroid Surgery (13 papers) and Head and Neck Anomalies (10 papers). Ian D. Hay is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (20 papers), Thyroid and Parathyroid Surgery (13 papers) and Head and Neck Anomalies (10 papers). Ian D. Hay collaborates with scholars based in United States, Sweden and Finland. Ian D. Hay's co-authors include Bryan McIver, Geoffrey B. Thompson, Megan S. Reinalda, Thomas J. Sebo, Juan P. Brito, John R. Goellner, Clive S. Grant, John C. Morris, J. William Charboneau and Carl C. Reading and has published in prestigious journals such as BMJ, Mayo Clinic Proceedings and American Journal of Roentgenology.

In The Last Decade

Ian D. Hay

23 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period

2008 578 citations Ian D. Hay, Bryan McIver et al. Surgery profile →

Peers

Countries citing papers authored by Ian D. Hay

Since Specialization

Citations

This map shows the geographic impact of Ian D. Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian D. Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian D. Hay more than expected).

Fields of papers citing papers by Ian D. Hay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian D. Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian D. Hay. The network helps show where Ian D. Hay may publish in the future.

Co-authorship network of co-authors of Ian D. Hay

This figure shows the co-authorship network connecting the top 25 collaborators of Ian D. Hay. A scholar is included among the top collaborators of Ian D. Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian D. Hay. Ian D. Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can Ethanol Ablation Achieve Durable Control of Neck Nodal Recurrences in Adults With Stage I Papillary Thyroid Cancer? 2024 ·Journal of the Endocrine Society ·Ian D. Hay, Robert A. Lee, Carl C. Reading, J. William Charboneau	1
2	Long-term Effectiveness of Ethanol Ablation in Controlling Neck Nodal Metastases in Childhood Papillary Thyroid Cancer 2023 ·Journal of the Endocrine Society ·Ian D. Hay, Robert A. Lee, Carl C. Reading, Siobhán T. Pittock, Animesh Sharma, Geoffrey B. Thompson, J. William Charboneau	2
3	Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome? 2022 ·European Thyroid Journal ·Ian D. Hay, (unknown), Geoffrey B. Thompson	7
4	Inability of Radioiodine Remnant Ablation to Improve Postoperative Outcome in Adult Patients with Low-Risk Papillary Thyroid Carcinoma 2021 ·Mayo Clinic Proceedings ·Ian D. Hay, (unknown), Nicole M. Iñiguez‐Ariza, Megan S. Reinalda, Gregory A. Wiseman, Geoffrey B. Thompson	10
5	Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century 2021 ·Mayo Clinic Proceedings ·Natalia Genere, (unknown), Rachel Giblon, Salvatore Vaccarella, John C. Morris, Ian D. Hay, Juan P. Brito	12
6	Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades 2020 ·Thyroid ·Anupam Kotwal, Dana Erickson, Jennifer R. Geske, Ian D. Hay, M. Regina Castro	46
7	The role of radioactive iodine in the management of patients with differentiated thyroid cancer – An oncologic surgical perspective 2020 ·European Journal of Surgical Oncology ·Iain J. Nixon, Jatin P. Shah, Mark Zafereo, Ricard Simó, Ian D. Hay, Carlos Suárez, Peter Zbären, Alessandra Rinaldo, Álvaro Sanabria, Carl E. Silver, Antti Mäkitie, Vincent Vander Poorten, Luiz Paulo Kowalski, Ashok R. Shaha, Gregory W. Randolph, Alfio Ferlito	13
8	Elimination of Locoregional Recurrences and Skin Metastases in Papillary Thyroid Cancer by Ethanol Ablation and Mohs Surgery 2020 ·Journal of the Endocrine Society ·Nicole M. Iñiguez‐Ariza, Robert A. Lee, Jerry D. Brewer, Ian D. Hay	4
9	88 ^th Annual Meeting of the American Thyroid Association 2018 ·Thyroid ·Gary L. Clayman, Ian D. Hay, Mimi I. Hu, Lori J. Wirth, (unknown), (unknown), (unknown), George J. Kahaly, Raymond S. Douglas, Robert J. Holt, (unknown), Julie Ball, Terry J. Smith, Seong‐Keun Yoo, Yoo Sung Song, Yongjung Park	6
10	Management of Papillary Thyroid Microcarcinoma 2018 ·Endocrinology and Metabolism Clinics of North America ·Juan P. Brito, Ian D. Hay	39
11	Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence 2015 ·Surgery ·Ian D. Hay, (unknown), Geoffrey B. Thompson, Thomas J. Sebo, Megan S. Reinalda	64
12	The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012 2015 ·Thyroid ·Juan P. Brito, Alaa Al Nofal, Víctor M. Montori, Ian D. Hay, John C. Morris	93
13	Low risk papillary thyroid cancer 2014 ·BMJ ·Juan P. Brito, Ian D. Hay, John C. Morris	96
14	Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected “recurrent” neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy 2013 ·Surgery ·Ian D. Hay, Robert A. Lee, Caroline Davidge‐Pitts, Carl C. Reading, J. William Charboneau	79
15	Interoperability for Device Manufacturers : Building a Personal, Connected Health Ecosystem 2012 ·Biomedical Instrumentation & Technology ·Ian D. Hay, (unknown), (unknown)	2
16	Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period breakdown → 2008 ·Surgery ·Ian D. Hay, (unknown), (unknown), Bryan McIver, Megan S. Reinalda, Clive S. Grant, Geoffrey B. Thompson, Thomas J. Sebo, John R. Goellner	578
17	Management of Patients With Low-Risk Papillary Thyroid Carcinoma 2007 ·Endocrine Practice ·Ian D. Hay	112
18	Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma 2006 ·Journal of Surgical Oncology ·Ian D. Hay	73
19	Nodular Thyroid Disease Diagnosed During Pregnancy: How and When to Treat 1999 ·Thyroid ·Ian D. Hay	15
20	Serum Immunoreactive Melatonin in Boys with Idiopathic Delayed Puberty 1982 ·Clinical Science ·Ian D. Hay, H. N. COHEN, Thomas M Annesley, (unknown), (unknown), J. Thomson, (unknown), George G. Klee	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact